You are here

lung cancer

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Fierce Pharma

PD-1 inhibitors

Flag link:

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab

Forbes

type 2 diabetes

Flag link:

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

FDA promises Roche a snap decision on Tecentriq triple for frontline lung cancer as it falls even further behind Merck, Bristol-Myers

Endpoints

Flag link:

We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated

We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated

San Francisco Gate, CA

Bristol-Myers Squibb

non-small cell lung cancer

Flag link:

Qiagen launches liquid biopsy tests for lung, prostate cancer

Qiagen launches liquid biopsy tests for lung, prostate cancer

Drug Delivery Business News

prostate cancer

Flag link:

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say

Biopharma Dive

Flag link:

With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace

With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace

Xconomy

immuno-oncology

Flag link:

Visiongate Announces Next Step in Commercialization of Cancer Detection Platform

Visiongate Announces Next Step in Commercialization of Cancer Detection Platform

CP Wire

LuCED Lung Test

Flag link:

Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib

Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib

Endpoints

priority review

Flag link:

Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week

Roche's Avastin could get a boost with Tecentriq's second lung cancer win this week

Fierce Pharma

Flag link:

Roche's Tecentriq cocktail notches another lung cancer success

Roche's Tecentriq cocktail notches another lung cancer success

Yahoo/Reuters

clinical trials

Flag link:

Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?

Is AbbVie 'Unraveling' In Solid Tumor Market After Drug Misstep?

Investors Business Daily

Flag link:

Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Auris Health’s Surgical Robot Gets FDA Green Light for Lung Cancer

Xconomy

robotic surgery

Flag link:

Is It Game Over for AbbVie's Promising Cancer Drug?

Is It Game Over for AbbVie's Promising Cancer Drug?

Motley Fool

Flag link:

AbbVie says not seeking accelerated approval for lung cancer drug

AbbVie says not seeking accelerated approval for lung cancer drug

Yahoo/Reuters

accelerated approvals

Flag link:

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

FDA OK makes AstraZeneca the leader in one new segment of the all-important lung cancer market

Endpoints

Flag link:

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial

Yahoo/Reuters

clinical trials

Flag link:

Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment

Genprex Launch IPO For Trials Of New Gene Therapy Lung Cancer Treatment

Forbes

Flag link:

Merck's Keytruda extends lung cancer survival in combination trial

Merck's Keytruda extends lung cancer survival in combination trial

Yahoo/Reuters

clinical trials

Flag link:

Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst

Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst

Fierce Pharma

Flag link:

Pages